Table 2.
Antimicrobial cystatin C pharmacokinetic study
| Drug | Study | Population | Analytical methods | Renal function | Renal function-PK | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of patients | Patients | Age range (years) | Creatinine | CysC | Drug | GFR based on creatinine | GFR based on CysC | Significant correlation between CysC and drug clearances (r2) | Significant correlation between CysC and drug C0 (r2) | CysC is better correlated with PK compared to creatinine (r2) | ||
| Vancomycin | Chen et al. 30 | 65 | Adult and elderly patients | 19–78 | Enzymatic | PETIA | FPIA | Creatinine clearance* | Flodin† | Yes (0.85) | ― | Yes (0.64) |
| Tanaka et al. 54 | 60 | Adult patients | 16–64 | ― | PENIA | ― | CG¶¶ | Hoek‡ | ― | Yes (0.78) | Yes (0.54) | |
| 105 | Elderly patients | 66–95 | ― | PENIA | ― | CG | Hoek | ― | Yes (0.79) | Yes (0.18) | ||
| Kees et al. 31 | 25 | Critically ill adults and elderly patients | 31–82 | Enzymatic | PENIA | HPLC | CG | Hoek | Yes (0.70) | ― | Yes (0.37) | |
| Suzuki et al. 32 | 18 | Adult patients | ― | Enzymatic | PENIA | FPIA | CG/ MDRD§ | Rules¶/Hoek | ― | Yes (0.42/0.49) | Yes (0.13/0.19) | |
| Tanaka et al. 33 | 164 | Adult and elderly patients | 17–95 | ― | PENIA | FPIA | ― | Hoek | Yes (0.84) | ― | ― | |
| Okamoto et al. 34 | 24 | Elderly patients | 66–87 | Enzymatic | PETIA | FPIA | CG | Larsson** | Yes (0.78) | ― | Yes (0.47) | |
| Chung et al. 35 | 678 | Adult and elderly patients | 18–96 | Jaffé | PETIA | FPIA | CG | Concentration | Yes | ― | Yes | |
| Amikacin | Halacova et al. 36 | 71 | Adults and children with cystic fibrosis | 4–28 | Enzymatic | PETIA | FPIA | CG / Schwatz†† | Grubb‡‡/Larsson | Yes | ― | Yes |
| Cefuroxime | Viberg et al. 37 | 97 | Adult patients | 24–95 | Enzymatic | PENIA | HPLC | Concentration | Concentration | ― | Yes | Yes |
| Arbekacin | Otsuka et al. 38 | 95 | Adult and elderly patients | 73–16 | Enzymatic | PENIA | FPIA | CG | Sjöström§§ | ― | Yes (0.89) | Yes (0.64) |
CG, Cockcroft–Gault equation
CysC, cystatin C
FPIA, fluorescence polarization immunoassay
HPLC, high-performance liquid chromatography
MDRD, modification of diet in renal disease equation
PENIA, particle-enhanced nephelometric immunoassay
PETIA, particle-enhanced turbidimetric immunoassay.
Creatinine clearance = creatinine concentration in urine x urine flow rate / plasma creatinine concentration.
Flodin equation: eGFR = 79.901 × CysC–1.4389.
Hoek equation: eGFR = (80.35 / CysC) – 4.32.
MDRD equation: eGFR = 186.3 × (creatinine / 88.4) –1.154 × age–0.203 × 0.742 (if female) × 1.21 (if African).
Rules equation: eGFR = 66.8 × CysC –1,3.
Larsson equation: eGFR = 99.43 × CysC–1.5837.
Schwartz equation: eGFR = k × height / serum creatinine; the value of k varies as a function of age and gender being 0.33 in preterm infants, 0.45 in term infants, 0.55 in child or adolescent girls and 0.7 in adolescent boys.
Grubb equation: eGFR = 84.69 × CysC–1.68 × 1.384 (if a child <14 years).
Sjöström equation eGFR = (124 / CysC) – 22.3.
Cockroft–Gault: eGFR= k × weight × (140 – age) / creatinine; the value of k is 1.23 for men and 1.04 for women.